Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2022-01-03 00:00:00 ET · period of report 2022-01-01 · accession 0000921895-22-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | 2022-01-01 | HBIO | Dir | A - Grant | $0.00 | +2,525 | 185.6K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-01 | A | A | 2,525 | $0.00 | 185,626 | D | — | — | (F1) Represents an award of 2,525 restricted stock units that will vest in full on the date of the Issuer's 2022 Annual Meeting of the Stockholders. (F2) Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, and (c) 168,701 shares of common stock held by the Reporting Person. |